cms_WV: 4048

In collaboration with The Seattle Times, Big Local News is providing full-text nursing home deficiencies from Centers for Medicare & Medicaid Services (CMS). These files contain the full narrative details of each nursing home deficiency cited regulators. The files include deficiencies from Standard Surveys (routine inspections) and from Complaint Surveys. Complete data begins January 2011 (although some earlier inspections do show up). Individual states are provides as CSV files. A very large (4.5GB) national file is also provided as a zipped archive. New data will be updated on a monthly basis. For additional documentation, please see the README.

Data source: Big Local News · About: big-local-datasette

This data as json, copyable

rowid facility_name facility_id address city state zip inspection_date deficiency_tag scope_severity complaint standard eventid inspection_text filedate
4048 TAYLOR HEALTH CARE CENTER 515057 2 HOSPITAL PLAZA GRAFTON WV 26354 2017-03-01 428 D 0 1 WA6611 **NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on record review and staff interview, the facility failed to ensure the physician responded to a pharmacy recommendation for the gradual dose reduction of an antipsychotic medication in a timely manner. This practice was found for one (1) of five (5) Stage 2 sample residents reviewed for unnecessary medications. Resident identifier: #10. Facility census: 61. Findings include: a) Resident #10 On 02/21/17 at 1:17 p.m., medical record review revealed this Resident #10, admitted on [DATE], had [DIAGNOSES REDACTED]. He was currently receiving Risperdal (an antipsychotic medication) 0.25 milligrams (mg) by mouth daily twice a day (BID) for schizoaffective disorder. The pharmacist's consultation report dated 02/03/16 noted the resident was receiving Risperdal 0.25 mg BID. The pharmacist recommended, Please consider a gradual dose reduction (GDR) while monitoring for re-emergence of target and/or withdrawal symptoms. The physician signed the report on 03/08/16 declining the recommendation of a GDR for the antipsychotic medication Risperdal (and provided the rationale for declining the recommendation). The Director of Nursing (DON) signed the report on 03/23/16. After reviewing the pharmacy consultation report on 02/27/17 at 12:40 p.m., the DON stated, I anticipate the GDRs being returned with physician decline or acceptance within two (2) weeks. Absolutely that is not a timely response as you can see it was over a month before he (Physician) filled out the form and longer for him (Physician) to return it to me, of course it is not timely. 2020-02-01